![]() ![]() HRU data were collected retrospectively for the 97 day period before enrolment and prospectively every 90 days for up to 18–21 months following enrolment. Investigators collected baseline demographic data and medical history at patient enrolment. Preventing SREs in patients with advanced prostate cancer and bone metastases may help to reduce the burden to both patients and European healthcare systems. All SREs are associated with substantial HRU. ![]() Overall, 174 SREs (78%) required an outpatient visit and the mean number of visits per SRE was 4.6 (SD 4.6). Of the 222 SREs included in this analysis, 26% were associated with inpatient stays and the mean duration per SRE was 21.4 days (standard deviation (SD) 17.8 days). HRU, including the number and duration of inpatient hospitalizations, number of outpatient and emergency department visits and procedures, was independently attributed by investigators to an SRE. HRU data were collected retrospectively for 97 days before enrolment and prospectively for up to 18–21 months. ![]() They had bone metastases secondary to prostate cancer and had experienced at least one SRE in the 97 days before giving informed consent. A total of 120 patients from Germany, Italy, Spain and the United Kingdom were enrolled in this observational study. This study aimed to increase the understanding of health resource utilization (HRU) associated with skeletal-related events (SREs) occurring in patients with bone metastases secondary to advanced prostate cancer. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |